INS and obesity disorder: The ability of caffeine to inhibit amine oxidases and to impair basal and insulin-stimulated glucose uptake and incorporation into lipids of adipocytes has to be added to its well-known lipolytic and thermogenic properties, indicating that caffeine and related methylxanthines are still of potential interest for the treatment or prevention of obesity.